AXIM BIOTECHNOLOGIES, INC. Liabilities Assumed
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Liabilities Assumed of $1.84 million for the 3-month period ending 2020-03-31, per its 10-Q/A filed 2020-07-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2020-07-02
- AXIM BIOTECHNOLOGIES, INC. liabilities assumed for the quarter ending 2020-03-31 was $1.84M.
- AXIM BIOTECHNOLOGIES, INC. liabilities assumed for the quarter ending 2019-03-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. liabilities assumed for the quarter ending 2017-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. liabilities assumed for the quarter ending 2016-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. liabilities assumed for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- AXIM BIOTECHNOLOGIES, INC. liabilities assumed for fiscal 2016 was $1.48M.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|
| 2020-03-31 | $1.84M 10-Q/A · filed 2020-07-02 | ||
| 2019-03-31 | $0.00 10-Q/A · filed 2020-07-02 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-20 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.48M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $1.48M 10-Q · filed 2017-11-20 |